Returns At Q & M Dental Group (Singapore) (SGX:QC7) Appear To Be Weighed Down

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. So, when we ran our eye over Q & M Dental Group (Singapore)'s (SGX:QC7) trend of ROCE, we liked what we saw.

Advertisement

Understanding Return On Capital Employed (ROCE)

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Q & M Dental Group (Singapore), this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.11 = S$26m ÷ (S$274m - S$30m) (Based on the trailing twelve months to December 2020).

Therefore, Q & M Dental Group (Singapore) has an ROCE of 11%. In absolute terms, that's a satisfactory return, but compared to the Healthcare industry average of 8.4% it's much better.

View our latest analysis for Q & M Dental Group (Singapore)

roce
SGX:QC7 Return on Capital Employed April 1st 2021

Above you can see how the current ROCE for Q & M Dental Group (Singapore) compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Q & M Dental Group (Singapore) here for free.

What Does the ROCE Trend For Q & M Dental Group (Singapore) Tell Us?

While the returns on capital are good, they haven't moved much. The company has consistently earned 11% for the last five years, and the capital employed within the business has risen 40% in that time. 11% is a pretty standard return, and it provides some comfort knowing that Q & M Dental Group (Singapore) has consistently earned this amount. Over long periods of time, returns like these might not be too exciting, but with consistency they can pay off in terms of share price returns.

In Conclusion...

In the end, Q & M Dental Group (Singapore) has proven its ability to adequately reinvest capital at good rates of return. And given the stock has only risen 12% over the last five years, we'd suspect the market is beginning to recognize these trends. So to determine if Q & M Dental Group (Singapore) is a multi-bagger going forward, we'd suggest digging deeper into the company's other fundamentals.

One more thing, we've spotted 4 warning signs facing Q & M Dental Group (Singapore) that you might find interesting.

While Q & M Dental Group (Singapore) may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

When trading Q & M Dental Group (Singapore) or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted


Valuation is complex, but we're here to simplify it.

Discover if Q & M Dental Group (Singapore) might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About SGX:QC7

Q & M Dental Group (Singapore)

An investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China.

Adequate balance sheet with moderate growth potential.

Advertisement

Weekly Picks

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Looking to be second time lucky with a game-changing new product

Fair Value:US$21.5362.1% undervalued
132 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18053.7% undervalued
5 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
DO
Double_Bubbler
LUNR logo
Double_Bubbler on Intuitive Machines ·

Intuitive Machines: To The Moon and Beyond!

Fair Value:US$42.324.1% undervalued
4 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
YI
APP logo
yiannisz on AppLovin ·

AppLovin’s AI Engine Is Printing Profit

Fair Value:US$989.2450.4% undervalued
22 users have followed this narrative
1 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

OI
MVO logo
Oily on MV Oil Trust ·

Poor analysis here will mislead investors

Fair Value:US$2.11.0% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ZH
zhalia
LYC logo
zhalia on Lynas Rare Earths ·

Lynas Rare Earths to Shine with 281% Future P/E Surge

Fair Value:AU$22.8714.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
ROP logo
kapirey on Roche Holding ·

Roche is a cash-generating, defensive large-cap pharma, with upside driven by pipeline execution.

Fair Value:CHF 353.349.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.1% undervalued
108 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.227.7% undervalued
70 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74018.5% undervalued
35 users have followed this narrative
3 users have commented on this narrative
33 users have liked this narrative